Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin D deficiency: An exploratory, double blind, randomised controlled trial

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Dreyer, Gavin ^a,b   Tucker, Arthur T ^a   Harwood, Steven M ^b   Pearse, Rupert M ^a   Raftery, Martin J ^a   Yaqoob, Muhammad M ^a,b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADVANCED GLYCATION END PRODUCT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERGOCALCIFEROL; NITRITE; PLACEBO; VITAMIN;

ADULT; ARTICLE; BLOOD PRESSURE; BONE MINERAL; CAPILLARY DENSITY; CAPILLARY FLOW; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; EXPLORATORY RESEARCH; FEMALE; GOUT; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN CELL; HYPERCALCEMIA; IN VITRO STUDY; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; VASODILATATION; VITAMIN D DEFICIENCY; DRUG ADMINISTRATION; DRUG EFFECTS; KIDNEY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME; VASCULARIZATION;

ADMINISTRATION, ORAL; ADULT; COMORBIDITY; DRUG ADMINISTRATION SCHEDULE; ERGOCALCIFEROLS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY; MALE; MICROCIRCULATION; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84904136921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099461     Document Type: Article

References (55)

1. Feehally J, Griffith KE, Lamb EJ, O'Donoghue DJ, Tomson CR (2008) Early detection of chronic kidney disease. BMJ 337: a1618.
2. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, et al. (2002) 1,25- Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238. (Pubitemid 34787360)
3. Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, et al. (1992) 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4: 506-512.
4. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS (2007) 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50: 69-77. (Pubitemid 46962855)
5. Blair D, Byham-Gray L, Lewis E, McCaffrey S (2008) Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr 18: 375-382. (Pubitemid 351818240)
6. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, et al. (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45: 1026-1033. (Pubitemid 40806515)
7. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S (2011) Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 58: 374-382.
8. de Boer IH, Katz R, Chonchol M, Ix JH, Sarnak MJ, et al. (2011) Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol 6: 2141-2149.
9. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, et al. (2009) 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 20: 1805-1812.
10. Chitalia N, Recio-Mayoral A, Kaski JC, Banerjee D (2012) Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 220: 265-268.
11. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC (2011) Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease - a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 216: 446-451.
12. Tatematsu S, Wakino S, Kanda T, Homma K, Yoshioka K, et al. (2007) Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol 18: 741-749. (Pubitemid 46434491)
13. Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, et al. (2000) Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 57: 1091-1099. (Pubitemid 30434798)
14. Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA (2004) Surrogate markers for cardiovascular disease: functional markers. Circulation 109: IV31-46.
15. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, et al. (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16: 1115-1125. (Pubitemid 41710323)
16. Andress DL (2006) Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 69: 33-43.
17. Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B (2008) Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 19: 1613-1619.
18. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, et al. (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70: 1858-1865. (Pubitemid 44684819)
19. Wolf M, Thadhani R (2007) Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. J Steroid Biochem Mol Biol 103: 487-490. (Pubitemid 46401279)
20. Santoro D, Gitto L, Ferraro A, Satta E, Savica V, et al. (2011) Vitamin D status and mortality risk in patients with chronic kidney disease. Ren Fail 33: 184-191.
21. Talmor Y, Golan E, Benchetrit S, Bernheim J, Klein O, et al. (2008) Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294: F1059-1064.
22. Borges AC, Feres T, Vianna LM, Paiva TB (1999) Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 34: 897-901. (Pubitemid 29501320)
23. Wong MS, Delansorne R, Man RY, Vanhoutte PM (2008) Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 295: H289-296.
24. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, et al. (2011) Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med 9: 125.
25. Sugden J DJ, Witham M, Morris A, Struthers A (2007) Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabetic Medicine 25: 320-325.
26. Assimon MM, Salenger PV, El-Fawal HA, Mason DL (2012) Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit? Nephrology (Carlton) 17: 237-242.
27. Marckmann P, Agerskov H, Thineshkumar S, Bladbjerg EM, Sidelmann JJ, et al. (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant.
28. Clough G, Cracowski JL (2012) Spotlight issue: Microcirculation-from a clinical perspective. Microcirculation 19: 1-4.
29. Pignocchino P, Conte MR, Scarnato S, Grande A (1994) [Study of cutaneous microcirculation using the laser-Doppler method in syndrome X]. Cardiologia 39: 193-197.
30. Economides PA, Caselli A, Zuo CS, Sparks C, Khaodhiar L, et al. (2004) Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism 53: 222-227. (Pubitemid 38168895)
31. Tur E, Yosipovitch G, Bar-On Y (1991) Skin reactive hyperemia in diabetic patients. A study by laser Doppler flowmetry. Diabetes Care 14: 958-962.
32. Jung F, Mrowietz C, Labarrere C, Schuler S, Park JW (2001) Primary cutaneous microangiopathy in heart recipients. Microvasc Res 62: 154-163. (Pubitemid 32885702)
33. Shamim-Uzzaman QA, Pfenninger D, Kehrer C, Chakrabarti A, Kacirotti N, et al. (2002) Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: a comparative study with conduit vessel responses. Clin Sci (Lond) 103: 267-273. (Pubitemid 35007218)
34. McIntyre C JS, Jefferies H (2008) Advances in the cardiovascular assessment of patients with chronic kidney disease. NDT Plus 6: 383-391.
35. de Boer IH, Kestenbaum B (2008) Vitamin D in chronic kidney disease: is the jury in? Kidney Int 74: 985-987.
36. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470. (Pubitemid 29135798)
37. (2003) K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42: S1-S201.
38. Cupisti A, Rossi M, Placidi S, Caprioli R, Morelli E, et al. (2000) Responses of the skin microcirculation to acetylcholine and to sodium nitroprusside in chronic uremic patients. Int J Clin Lab Res 30: 157-162. (Pubitemid 32122092)
39. Cupisti A, Rossi M, Placidi S, Fabbri A, Morelli E, et al. (2000) Responses of the skin microcirculation to acetylcholine in patients with essential hypertension and in normotensive patients with chronic renal failure. Nephron 85: 114-119. (Pubitemid 30330533)
40. Morris SJ, Shore AC, Tooke JE (1995) Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 38: 1337-1344.
41. Droog EJ, Henricson J, Nilsson GE, Sjoberg F (2004) A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects. Microvasc Res 67: 197-202. (Pubitemid 38327006)
42. Gerrits EG, Smit AJ, Bilo HJ (2009) AGEs, autofluorescence and renal function. Nephrol Dial Transplant 24: 710-713.
43. De Backer D, Hollenberg S, Boerma C, Goedhart P, Buchele G, et al. (2007) How to evaluate the microcirculation: report of a round table conference. Crit Care 11: R101.
44. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE (1993) Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci U S A 90: 8103-8107. (Pubitemid 23260863)
45. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, et al. (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376: 1543-1551.
46. Molina P, Gorriz JL, Molina MD, Peris A, Beltran S, et al. (2013) The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Nephrol Dial Transplant.
47. Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, et al. (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307: 674-684.
48. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, et al. (2009) Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94: 4023-4030.
49. Rashid G, Benchetrit S, Fishman D, Bernheim J (2004) Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int 66: 1099-1106. (Pubitemid 39121015)
50. Arese M, Strasly M, Ruva C, Costamagna C, Ghigo D, et al. (1995) Regulation of nitric oxide synthesis in uraemia. Nephrol Dial Transplant 10: 1386-1397.
51. Witham MD, Adams F, Kabir G, Kennedy G, Belch JJ, et al. (2013) Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK - A randomised controlled trial. Atherosclerosis 230: 293-299.
52. Hobbs DA, Goulding MG, Nguyen A, Malaver T, Walker CF, et al. (2013) Acute ingestion of beetroot bread increases endothelium-independent vasodilation and lowers diastolic blood pressure in healthy men: a randomized controlled trial. J Nutr 143: 1399-1405.
53. Tehrani S, Mobarrez F, Lins PE, Adamson U, Wallen HN, et al. (2013) Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes. Diab Vasc Dis Res 10: 483-488.
54. Kaiser SE, Sanjuliani AF, Estato V, Gomes MB, Tibirica E (2013) Anti- Hypertensive Treatment Improves Microvascular Rarefaction and Reactivity in Low-Risk Hypertensive Individuals. Microcirculation.
55. Pellegatta F, Bragheri M, Grigore L, Raselli S, Maggi FM, et al. (2006) In vitro isolation of circulating endothelial progenitor cells is related to the high density lipoprotein plasma levels. Int J Mol Med 17: 203-208.